Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator.

Slathering on sunscreen? You might be blocking more than just a tan. Find out the truth that no one is talking about.

Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Wednesday. Separately, HC Wainwright ...

Researchers suggest drugs that prevent cholesterol from being converted to 24-OHC might therefore be an effective treatment for Parkinson's disease.

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its price target hoisted by Scotiabank from $49.00 to $52.00 in a research ...

After hours: February 21 at 4:05:03 PM EST Loading Chart for AGIO ...

After hours: February 21 at 7:52:05 PM EST Loading Chart for BBIO ...

AstraZeneca will obtain the full rights to Roxadustat in China, FibroGen said, adding that it will retain the US and other ...

以前，我们对 STN - DBS 潜在的神经保护作用只是猜测，现在研究人员通过实验证实了它在减少 TrkB 簇形成和保护多巴胺能神经元方面的作用。这不仅让我们对大脑中复杂的神经调节机制有了更深入的了解，也为未来开发更有效的帕金森病治疗方法提供了重要线索。比如，我们可以根据这些发现，进一步优化 STN - DBS 的治疗方案，找到最佳的刺激参数，提高治疗效果。而且，TrkB ...